Does a Minimally Invasive Approach to Liver Resection Improve Postoperative Outcomes?

A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify adult patients who underwent liver resection between 2022 and 2023. Primary outcomes included 30-day mortality, sepsis, septic shock, readmission, and reoperation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hepatic Neoplasms Digestive System Diseases Digestive System Neoplasms Liver Diseases Liver Neoplasms Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Icahn School of Medicine at Mount Sinai

New York, 10029, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Retrospective patients with condition only

Exclusion criteria

none

Treatment and study plan

Primary outcomes

30-day mortality

Time frame: 30 days

Number of deaths at 30 days
Number of participants with Sepsis

Time frame: 30 days

Number of participants with sepsis at 30 days
Number of participants with Septic Shock

Time frame: 30 days

Number of participants with septic shock at 30 days
Number of readmissions

Time frame: 30 days

Number of participants who had a remission at 30 days
Number of reoperations

Time frame: 30 days

Number of participants who had an reoperation at 30 days

Sponsors and collaborators

Lead sponsor

Icahn School of Medicine at Mount Sinai

Other

Registry information

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2023
First posted: Sep 12, 2025
Registry last updated: Sep 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed